ENTA Enanta Pharmaceuticals, Inc.
Healthcare$13.53-3.01%ClosedMarket Cap: $314.1M
As of 2026-05-26
Insider Statistics (Q1 2026)
Acquisitions
18
Dispositions
6
Buy/Sell Ratio
3.00
Net Shares
+150,970
Shares Acquired
172,367
Shares Disposed
21,397
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Mar 13 | Vance Terry | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | Russell Lesley | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | Peterson Kristine | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | Hata Yujiro S | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | FOLETTA MARK G | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Mar 13 | CARTER BRUCE L A | director | Sell | 20,000 | $14.17 | 20,000 |
| Fri Feb 13 | Luu Brendan | officer: Chief Business Officer | Sell | 4,987 | $0.00 | 44,891 |
| Fri Feb 13 | Kowalsky Matthew Paul | officer: Chief Legal Officer | Sell | 1,902 | $14.25 | 3,591 |
| Fri Feb 13 | Kowalsky Matthew Paul | officer: Chief Legal Officer | Sell | 4,175 | $0.00 | 5,493 |
| Fri Feb 13 | Kowalsky Matthew Paul | officer: Chief Legal Officer | Sell | 1,318 | $0.00 | 1,318 |